FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064238 [Registered on: 15/03/2024] Trial Registered Prospectively
Last Modified On: 07/03/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A comparative study of two different opioids in two different routes for postoperative analgesia in patients undergoing major abdominal surgeries 
Scientific Title of Study   A comparative study between transdermal buprenorphine patch versus intravenous fentanyl for postoperative analgesia in patients undergoing major abdominal surgeries under general anaesthesia 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR Sahana BV 
Designation  PG Student, MD Anaesthesia 
Affiliation  Bangalore medical college and research institute 
Address  Department of Anaesthesiology, Bangalore medical college and research institute
No 19, kaveri nilaya, SNT street, sreenivasanagar, bangalore, 560085
Bangalore
KARNATAKA
560002
India 
Phone  9686177897  
Fax    
Email  sahanavenkatramu1997@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Asha N 
Designation  Assistant professor 
Affiliation  bangalore medical college and research institute 
Address  Department of anaesthesiology,bangalore medical college and research institute,KR Road, Bangalore

Bangalore
KARNATAKA
560002
India 
Phone  9900622335  
Fax    
Email  ashamshu@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Asha N 
Designation  Assistant professor 
Affiliation  bangalore medical college and research institute 
Address  Department of anaesthesiology,bangalore medical college and research institute,KR Road, Bangalore

Bangalore
KARNATAKA
560002
India 
Phone  9900622335  
Fax    
Email  ashamshu@gmail.com  
 
Source of Monetary or Material Support  
Bangalore medical college and research institute, KR road, Bangalore, 560002 
 
Primary Sponsor  
Name  Bangalore medical college and research institute 
Address  Bangalore medical college, research institute, kr road,560002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Dr Asha N  Bangalore medical college, research institute, kr road,560002 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sahana BV  Bangalore medical college and research institute  Department of Anesthesiology, Bangalore medical college and research institute, KR road, 560002
Bangalore
KARNATAKA 
9686177897

sahanavenkatramu1997@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bangalore medical college and research institute ethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  post operative patients 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Intravenous fentanyl  25mcg every 6th hourly for 3 days postoperatively 
Intervention  transdermal buprenorphine patch 5mcg/H  applied over hairless areas for 3 days post operatively  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with weight 40-80kgs.
Patients scheduled for open elective intraperitoneal abdominal surgeries under general anaesthesia
Patients giving informed written consent.
Patients belonging to ASA I, II.
 
 
ExclusionCriteria 
Details  1.Patients who refused to give informed written consent.
2.Patients with ASA physical status III or more.
3.Patients with known cardiac and pulmonary complications.
4.Patients with known allergy to opioids.
5.Patients with mental illness.
6.Pregnants and breastfeeding females.
7. Surgeries of duration > 3 hours.
8. Surgeries including surgical incision extended 5 cm above the umbilicus.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
visual analogue scale
 
Post operative day 1 to day 3
 
 
Secondary Outcome  
Outcome  TimePoints 
ramsay sedation scale
hemodynamic parameters
adverse effects 
post operative day 1 to 3 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   29/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Post operative pain is very common in major abdominal surgeries, and one of the major concerns for the patient undergoing major surgery. Pain in the first few days after surgery can lead to delayed ambulation, increase in cardiopulmonary and thrombotic morbidity as well the development of chronic pain.
Appropriate pain relief leads to shortened hospital stays, reduced hospital costs, increased patient satisfaction. Opioid is generally regarded as an important part of multimodal, perioperative analgesia, especially for moderate to severe pain. â€¢Buprenorphine is a semisynthetic opioid derivative of thebaine, being a potent and safe analgesic (75-100 times greater than that of morphine) at 5-10% receptors occupancy, causing less respiratory depression. Time to attain minimum therapeutic concentration after transdermal patch is 21 hours. Fentanyl is a potent synthetic opioid similar to morphine, but produces analgesia to great extent. IV Fentanyl has an appropriate effectiveness in acute pain relief and suitable doses have comparable effects to morphine, with shorter onset of action being 30-60 mins, onset of action being 60 seconds.
Traditional and most common approach of post operative analgesia includes usage of opioid drug like morphine or fentanyl taken intravenously.
Transdermal opioids are newer modality in use for the control of postoperative pain, because of its non invasiveness, longer duration of action, sustained blood levels and with minimal side effects
There fore, the need of this study is to compare between traditional and standard approach- Intravenous fentanyl versus newer modality transdermal buprenorphine in the management of  post operative pain, as there are very few studies quoted about them.
our study is randomized study conducted in bangalore medical college and research institute
conducted in 30 patients, 15 patients receiving transdermal buprenorphine as post operative analgesia  and other 15 receiving intravenous fentanyl as postoperative analgesia.
postoperatively pain will be asssessed by visual analogue scale, ramsay sedation score, hemodynamic parameters.
adverse effects caused by both the groups noted.
 
Close